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Alzheimer’s disease (AD) is increasingly referred to as a “synaptopathy.” This moniker
reflects the loss or damage of synapses that occurs as the disease progresses, which in
turn produces functional degeneration of specific neuronal circuits and consequent aber-
rant activity in neural networks. Accumulating evidence supports the functional importance
of the early-expression activity-regulated cytoskeletal (Arc) gene in regulating memory
consolidation. Interestingly, AD patients express anomalously high levels of Arc protein.
Arc physically associates with presenilin1, a pivotal protease for the generation of Amy-
loid β (Aβ) peptides. Arc expression itself is disrupted in the vicinity of Aβ oligomers and
plaques. Such alterations result in the interruption of neuronal network integration in vivo.
It is not clear what the impacts of these alterations are on the functional neurophysiology
of transgenic mouse models of AD-associated amyloidopathy. Our group and others have
described alterations to neuronal excitability and thus intrinsic firing within these transgenic
mice models. This brief review will emphasize the rising role of Arc and its involvement in
neurophysiological alterations of current AD models.
Keywords: Arc, amyloid beta protein, Alzheimer’s disease, neurophysiology, AMPA receptor trafficking, intrinsic
plasticity
INTRODUCTION
Alzheimer’s disease (AD) appears to be primarily a disorder of
synaptic failure (Selkoe, 2002) which is becoming one of the most
predictable features in the pathophysiology of the disease. This
“synaptopathy” is associated with disruptions in synaptic structure
and function, leading to aberrant neural processing and network
disruptions.
Early research on AD pathology focused attention on the
involvement of the amyloid precursor protein (APP) pathway and
the plaques formed by its proteolytic cleavage product Amyloid β
(Aβ; Glenner and Wong, 1984; Hardy and Higgins, 1992; Hardy
and Selkoe, 2002). Evidence accumulated in recent years has led to
the emergence of the soluble, oligomeric Aβ peptide playing a piv-
otal role in the disruption of synaptic function and thus neuronal
network activity (Walsh and Selkoe, 2004, 2007). Although pico-
molar concentrations of Aβ may play critical physiological roles
in synaptic plasticity (Puzzo et al., 2008) and activity-dependent
regulation of synaptic vesicle release (Abramov et al., 2009), abnor-
mal accumulations lead to the self-assembly of neurotoxic Aβ
oligomers, which interfere with synaptic function and cause neu-
rodegeneration. These alterations in classic neurophysiological
processes are believed to be the main substrates of cognitive decline
in AD.
Indeed, levels of soluble Aβ oligomers are highly correlated with
synaptic dysfunction in AD. It has been possible to monitor the
targeting of Aβ oligomers to synapses (Lacor et al., 2004; Desh-
pande et al., 2009), and to follow the changes in spine morphology
and density (Lacor et al., 2007). These synaptic alterations cor-
respond to the best pathological correlate of memory deficits in
AD (DeKosky and Scheff, 1990; Terry et al., 1991; Selkoe, 2002),
although the exact mechanisms are still unknown. The intriguing
targeting of Aβ oligomers to synapses and their disruption brought
our focus to one of the genes shown to be vital for memory consol-
idation and synaptic plasticity, namely the immediate-early gene
Arc/Arg3.1 (early-expression activity-regulated cytoskeletal gene,
here on referred to as Arc).
Arc is a neuron-specific, post-synaptic protein that is selec-
tively expressed in Ca2+/calmodulin-dependent protein kinases
II (CaMKII)-positive neurons (Vazdarjanova et al., 2006). Upon
activation, Arc is targeted to the post-synaptic density of synap-
tically active dendritic spines (Lyford et al., 1995; Steward and
Worley, 2001; Moga et al., 2004) where it associates with polysomes
(Bagni et al., 2000). Arc interacts with endophilin 2/3 and
dynamin, contributing to alpha-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate (AMPA) type glutamate receptor (AMPAR)
modulation, by enhanced receptor endocytosis (Chowdhury et al.,
2006). The Arc-endosome also traffics APP and physically asso-
ciates with presenilin (PS1), thereby increasing the amount of
activity-dependent Aβ generated (Wu et al., 2011). Interruption
of the Arc-PS1 interaction prevents activity-dependent increases
of Aβ (Wu et al., 2011). The precise signaling cascades involved
in Arc transcription are not well defined. For a more comprehen-
sive review on Arc function and signaling, the reader is referred
to: Tzingounis and Nicoll, 2006; Miyashita et al., 2008; Bramham
et al., 2010; Shepherd and Bear, 2011.
Arc-mediated endocytosis of AMPARs dampens the activity of
neuronal networks, enhancing the activity-dependent generation
of Aβ (Wu et al., 2011). If Arc-endosome trafficking and resul-
tant activity-dependent generation of Aβ remained unchecked, it
will create a positive feedback mechanism in which the synaptic
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removal of AMPAR will produce a significant loss of dendritic
spines and synaptic activity, resulting in synaptic failure, similar
to that observed in AD (Hsieh et al., 2006; Shankar et al., 2007; Li
et al., 2010).
This brief review will provide an overview of the importance of
“synaptopathy” in the pathogenesis of AD, with particular empha-
sis being placed on the rising role of Arc, in neurophysiology. We
aim to provide a critical assessment of the current literature, to
address the impact of altered Arc expression on the molecular and
cellular mechanisms underlying the functional neurophysiology
in transgenic mouse models of AD-associated amyloidopathy.
ARC AND SYNAPTIC TRANSMISSION
Processing of information for memory storage requires specific
patterns of activity that lead to the modification of synapse struc-
ture and eventually to changes in neural connectivity (Lamprecht
and LeDoux, 2004; Marrone, 2007). These modifications can be
defined as synaptic plasticity, of which, long-term potentiation
(LTP) and long-term depression (LTD) are the two main cellular
mechanisms that are associated with learning and memory (Bliss
and Collingridge, 1993; Kandel, 2001; Malenka, 2003).
Arc was first identified as a hippocampal transcript strongly
induced by epileptic seizures and synaptic plasticity-inducing elec-
trical stimulation in the rat hippocampus (Link et al., 1995; Lyford
et al., 1995). Arc is not expressed in presynaptic terminals or
axons, but it is notable that its mRNA and protein accumulate
in dendrites at sites of recent synaptic activity (Steward et al.,
1998). The induction of Arc synthesis upon neuronal activation
and its localization to active dendrites, make it a prime candi-
date for investigating the mechanisms underlying learning and
memory. The importance of Arc in learning and memory is
corroborated in Arc knock-out (KO) animals where loss of the
Arc gene results in unusual phenotypic behavior, wherein the
animals are able to retain short term memory formation, how-
ever long-term memories cannot be formed (Plath et al., 2006).
Reduced Arc expression in the hippocampus by infusion of anti-
sense oligodeoxynucleotides interferes with synaptic plasticity and
hippocampus-dependent learning and memory (Guzowski et al.,
2000).
It has been demonstrated that Arc transcripts are also induced
during certain behaviors. The exploration of a novel environment
induces Arc expression in a subset of context-activated pyrami-
dal neurons, and can therefore be associated with experience-
dependent forms of plasticity (Guzowski et al., 1999; Vazdarjanova
and Guzowski, 2004; Gao et al., 2010; Wibrand et al., 2012). The
specificity and characteristic time course of Arc mRNA induction
can be used to monitor neural circuit activation following behavior
episodes, as initially demonstrated by Guzowski et al. (1999, 2001).
They were able to detect from Arc RNA in situ hybridization studies
that in CA1 neurons, it is possible to distinguish between popula-
tions of neurons that responded to two different environments and
were able to reveal whether the same neuron was activated twice
(Guzowski et al., 1999). This unique correlation between RNA
expression and neuronal activity levels, allows for Arc mRNA to
be used as a tool for the detection of when and where activity
in response to learning is being altered. Arc expression itself dif-
fers between brain regions and cell types (e.g., CA1 from CA3),
suggesting that it plays an important role in detecting changes in
neuronal activity in an experience-dependent manner (Kelly and
Deadwyler, 2003; Daberkow et al., 2007; Miyashita et al., 2009).
Arc is also heavily involved in different forms of synaptic plastic-
ity, however to cover these is beyond the context of this article.
We therefore suggest the following reviews (Bramham et al., 2010;
Korb and Finkbeiner, 2011; Shepherd and Bear, 2011).
Episodic hippocampal-dependent memory loss, is the earliest
clinical sign of AD, and is thought to be a result of changes in
synaptic function rather than neuronal loss (Morrison and Hof,
1997; Arendt, 2009). In vivo brain imaging studies, using func-
tional magnetic resonance imaging (fMRI) have revealed aberrant
networking in brain regions linked to memory function (Sperling
et al., 2009). High levels of amyloid deposition are associated with
this aberrant default network, suggesting that amyloid pathology
in early stages of AD is linked to neural dysfunction, memory loss,
and aberrant synaptic plasticity (Sperling et al., 2009). Although
still unclear, a general picture is emerging in which Aβ oligomers
seem to highjack the molecular machinery necessary to induce
synaptic plasticity. It appears that Aβ induces aberrant synaptic
plasticity by inhibiting LTP, and more interestingly, by facilitat-
ing LTD, causing AMPAR endocytosis (Hsieh et al., 2006; Shankar
et al., 2007; Li et al., 2010).
To prevent these imbalances in synaptic plasticity from devel-
oping in normal physiology, neurons have developed a unique
mechanism which modulates their global levels of post-synaptic
AMPAR in response to the level of activity seen in the cells, as
expressed by the rate of action potential firing. This process is
known as synaptic scaling and is thought to maintain post-synaptic
action potential firing rates within certain bounds (average firing
rate; Turrigiano et al., 1998). Synaptic scaling is a cell-wide mech-
anism of plasticity, and is thus referred to as a form of homeostatic
plasticity (Fregnac, 1998; Galante et al., 2001). This form of plas-
ticity is particularly sensitive to the levels of Arc (Shepherd et al.,
2006; Turrigiano, 2007). Indeed,Arc KO animals as well as neurons
overexpressing Arc are not capable of maintaining this negative
feedback mechanism (Shepherd et al., 2006).
Although the detailed mechanisms through which Arc affects
hippocampal functions are still under investigation, recent evi-
dence has demonstrated a role of Arc in AMPAR trafficking, with
evidence pointing to regulation of AMPAR endocytosis (Chowd-
hury et al., 2006; Rial Verde et al., 2006; Shepherd et al., 2006).
Arc directly interacts with the endocytic machinery by binding to
endophilin 1 and dynamin 2, and selectively increasing the rate of
AMPAR recycling (Chowdhury et al., 2006; Shepherd et al., 2006).
These studies suggest that when Arc expression is low the steady
state of AMPAR trafficking will shift to increase the distribution of
AMPAR to the membrane (Shepherd et al., 2006). The inverse is
true under conditions of high Arc expression (see Figure 1). Arc is
therefore likely important for limiting the level of neuronal exci-
tation since Arc-mediated endocytosis of AMPARs will dampen
activity of neuronal networks.
Arc activity is capable of regulating AMPAR endocytosis and
both spine size and type. These distinct actions are all means
to modulate synaptic strength (Chowdhury et al., 2006; Peebles
et al., 2010). As outlined above it appears that Arc controls sur-
face expression of AMPAR in a homeostatic manner and acts to
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FIGURE 1 | Feedback mechanism for Arc-mediated AMPA receptor
endocytosis. An increase in neural firing leads to somatic alterations in
calcium levels, which causes increased activation in the nucleus to
enhance local translocation of Arc mRNA. This increase results in
enhanced Arc protein levels and increased AMPA receptor (AMPA-R)
endocytosis (A). This leads to a decrease in synaptic strength, which
subsequently returns firing rates back to target levels (B). In AD,
enhanced Arc expression due to hyperexcitability leads to a positive
feedback mechanism in which the dampening response of Arc is
limited.
keep surface levels and subunit composition optimal for Hebbian
plasticity in normal physiology (Shepherd et al., 2006; Gao et al.,
2010).
If Arc-mediated endocytosis remain unchecked, excessive mod-
ifications of synaptic strength might generate instability or altered
synchrony in neuronal networks, leading in turn to disease states
characterized by network imbalances, as observed in AD and
epilepsy (Driver et al., 2007; Bragin et al., 2009; Palop and Mucke,
2009). The AD-associated peptide, Aβ, depresses AMPA recep-
tor currents in brain slices and induces AMPAR endocytosis
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via a mechanism which is similar to Group 1 metabotropic
glutamate receptor (mGluR-LTD; Hsieh et al., 2006). There is
also further evidence that AMPAR trafficking is reduced in
certain transgenic mouse models overexpressing APP (Almeida
et al., 2005; Chang et al., 2006). Is it therefore plausible that
AD may follow a similar mechanism in which a disruption of
the Arc protein and its expression results in aberrant AMPAR
trafficking?
FUNCTIONAL NEUROPHYSIOLOGY IN AD MODELS – A
RISING ROLE FOR Arc?
A number of compelling findings suggest that Arc may contribute
to the cognitive deficits and Aβ-dependent alterations in synaptic
plasticity experienced in AD. In fact, oligomeric forms of Aβ have
been shown to induce Arc expression itself (Lacor et al., 2004).
The synaptic binding of Aβ was able to induce a sustained Arc
expression within minutes, leading to ectopic protein diffusion
throughout the dendrite (Lacor et al., 2004).
Intriguingly, some AD mouse models show a decrease in the
number of Arc-expressing cells in the cortex (Wegenast-Braun
et al., 2009), a reduced Arc mRNA expression following explo-
rative behavior (Palop et al., 2005; Wegenast-Braun et al., 2009),
and lower levels of Arc mRNA in Aβ-containing brain regions
(Dickey et al., 2004). Taken together, these data suggest that the
widespread Arc expression from acute Aβ exposure might be paral-
leled by down-regulated Arc signaling in transgenic animals which
continuously over-produce Aβ. Early-stage synaptic deterioration
may be explained by the age-dependent decreases in Arc mRNA
and therefore altered dendritic transport in some transgenic mice
(Dickey et al., 2003).
Along with the disruption in AMPAR trafficking, there may
be structural modifications in the architecture of the neurons
taking place, which could account for some of the neurophysiolog-
ical alterations experienced in AD (Jacobsen et al., 2006; Middei
et al., 2008). Indeed, post-mortem tissues from AD patients reveal
reduced spine density (Scheff et al., 1996). Several in vitro studies
have demonstrated that oligomeric Aβ causes a reduction in the
number and/or length of dendritic spines in hippocampal neurons
(Calabrese et al., 2007; Lacor et al., 2007; Shankar et al., 2007). Sim-
ilar to Arc KO mice, mouse AD models display similar decreases
in spine density and impairment of long-term memory (Jacobsen
et al., 2006; Peebles et al., 2010; Perez-Cruz et al., 2011).
A number of studies in mutant APP-expressing transgenic
models have indicated increased Arc activation in response to neu-
ronal activity (Grinevich et al., 2009; Perez-Cruz et al., 2011), as
shown in Table 1. In these studies the APP-based transgenic lines
were studied prior to plaque deposition, suggesting that soluble
oligomeric, rather than deposited fibrillar Aβ is responsible for
the enhanced Arc expression (Perez-Cruz et al., 2011). In fact, in
the Tg2576 mouse line, the observed loss in dendritic spines were
said to be attributed to a loss of inhibitory interneurons, which
resulted in hyperexcitability caused by enhanced glutamate and
calcium-mediated excitation, subsequently causing the enhanced
expression of Arc (Perez-Cruz et al., 2011). We have confirmed the
hippocampal network hyperexcitability described in this partic-
ular mouse line, along with a double mutant APPSWE/PS1M146L
(PSAPP) mutation and have found that hippocampal CA1 pyra-
midal cells have enhanced “burstiness” (Brown et al., 2011). Such
alterations in excitability could lead to the early disruption in
synchronous network activity (Brown et al., 2005; Driver et al.,
2007).
Although the increase in cellular excitability described above
occurs in the absence of changes to resting potential, it seems to
arise from alterations to voltage-gated Na+ channels (Brown et al.,
2011; Randall et al., 2012). These alterations in Na+ channels are
an age-dependent event that was absent from the early preplaque
Tg2576 mice (used in Perez-Cruz et al., 2011; Brown et al., 2011),
however present in the more aggressive Aβ generating PSAPP
mouse (Brown et al., 2011). We cannot rule out the involvement of
a possible bidirectional control of intrinsic excitability (Fan et al.,
2005; Brager and Johnston, 2007), as a result of enhanced neuronal
activity due to increased Aβ burden.
Interestingly, a recent study revealed that Arc increases the asso-
ciation of presenilin/γ-secretase with endosomes that traffic APP
(Wu et al., 2011). When binding of Arc to PS1 was interrupted
activity-dependent increases in Aβ ceased. These workers also
revealed that the level of Arc expression determines the burden of
Aβ in the APP-based model used. This was the first study to reveal
that Arc protein was capable of increasing the generation of Aβ
in vivo. Wu et al. (2011) further explored the role of Arc in AD by
examining the medial frontal cortex of post-mortem human tissue
of patients with AD. The levels of Arc protein were significantly
increased in the medial frontal cortex of patients with late stage
advanced AD (Braak Stage V and VI) when compared to their
non-demented age-matched controls. Based on this the authors
concluded that Arc expression could contribute to Aβ generation
and pathology in AD (Wu et al., 2011).
Another in vivo study revealed that amyloid plaques act locally
to aberrantly increase Arc expression in active neurons (Rudinskiy
et al., 2012). However, the proportion of neurons that were active
in the location of amyloid plaques was significantly decreased.
This variation in active neurons near pathological plaques could
provide an explanation to the discrepancies that exist in current
literature involving Arc expression in AD (Table 1). Moreover
this study provides valuable insight into the underlying mecha-
nisms which could contribute to the alterations experienced in the
“default mode network, DMN” (Raichle et al., 2001) of patients
with AD, which is currently being explored in clinical neurophys-
iology. fMRI studies and position emission tomography (PET) of
AD patients have revealed a distinct correlation between default
activity patterns in cortical regions in young adults prior to the
development of AD and topography of Aβ deposition in early
AD cases (Buckner et al., 2005; Sperling et al., 2009). This corre-
spondence raises the possibility of a relationship between activity
patterns in early adulthood and later Aβ deposition, providing
valuable information and possible insight into the development
of AD. Indeed, Rudinskiy et al. (2012) suggest that the pattern of
Arc expression reflects the nervous system responses to, and phys-
iological consolidation of, behavioral experience. They conclude
that disruptions in Arc patterns reveal plaque-associated interfer-
ence with neural network integration, which could ultimately lead
to the synaptopathy of AD.
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Table 1 | Summary of effects of AD-related pathologies onArc expression.
Species AD related model Level of Arc expression Brain region Reference
Mouse APP/PS1, APPDutch, and
APP23 (aged and young)
Decreased Hippocampus and neocortex Wegenast-Braun et al. (2009)
Mouse APP/PS1 Decreased Hippocampus Dickey et al. (2003, 2004)
Mouse hAPP (preplaque, FAD) Decreased Hippocampus (DG) and cortex Palop et al. (2005)
Human Neurons with NFT Decreased Hippocampus Ginsberg et al. (2000)
Mouse Synthetic Aβ Decreased Cortical primary cultures Echeverria et al. (2007)
Rat Synthetic Aβ Decreased Cortical primary cultures Wang et al. (2006), Chen et al. (2009)
Mouse TG2576 and APP/Lo
(preplaque)
Increase Hippocampus Perez-Cruz et al. (2011)
Mouse APP/PS1 (preplaque) Increase Hippocampus Grinevich et al. (2009)
Mouse Synthetic Aβ Increase Cortical primary cultures Wu et al. (2011)
Rat Synthetic Aβ Increase Hippocampal primary neurons Lacor et al. (2004)
Mouse 4–7 Month old hAPP-J20
(preplaque)
Both increase and
decrease
Hippocampus Palop et al. (2005)
Mouse TG2576 (aged) No change Hippocampus Cuadrado-Tejedor et al. (2011)
Mouse CRND8 (aged) No change Hippocampus Herring et al. (2012)
CONCLUDING REMARKS
Despite its well characterized role in synaptic plasticity, Arc’s
involvement in disease is less well understood. It appears that this
enigmatic protein plays an imperative role in the maintenance of
homeostatic neuronal activity, which if disrupted, presents itself
in pathology. In this review, we focused on some of the most valu-
able findings, providing a unique insight into the mechanisms
underlying cognitive decline associated with AD.
We have explored the role of Arc in different models of AD-
associated pathology, and experienced a range of fluctuations in
neurophysiological properties. Differences in vitro can be inter-
preted as the result of a number of variables that differ between
each of the reported studies, including differences in behavioral
assays performed. Not only do they include different brain regions,
they also include different strains and ages of mice studied. Differ-
ences in genetic background and gene inclusions can themselves
have profound effects on neurophysiology. Although a detailed
morphological analysis of changes in synaptic connectivity in the
AD brain over time is difficult and limited to the use of post-
mortem material, the generation of APP transgenic mice that
over-produce Aβ has enabled a better understanding of the func-
tional and morphological consequences of Aβ overproduction.
These studies further highlight the need to understand precisely
how Arc expression is affected in AD, and its consequent alter-
ations to neurophysiological function. Valuable evidence now
emerging from in vivo models can directly be correlated to clin-
ical studies. This provides further support for the continuation
of exploring the role of Arc in the synaptopathy of AD. Finally,
improving our understanding of the molecular mechanisms con-
tributing to maintaining or strengthening synapses may be an
interesting entry point for novel therapeutic intervention in many
neurodegenerative diseases.
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